Login to Your Account

Sequencing Star PacBio Gets Out IPO Window After Aegerion

By Trista Morrison

Thursday, October 28, 2010
The good news is that Pacific Biosciences Inc. raised a hefty $200 million in its initial public offering, pricing at the midpoint of its expected range and closing up on its first day of trading. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription